Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.14
+0.14 (1.40%)
At close: Jun 26, 2026, 4:00 PM EDT
10.07
-0.07 (-0.69%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $478.95 million as of June 26, 2026. Its market cap has increased by 93.53% in one year.
Market Cap
478.95M
Enterprise Value
409.01M
1-Year Change
93.53%
Ranking
Category
Stock Price
$10.14
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $478.95M, a decrease of -11.04%. That is a compound annual growth rate of -2.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 478.95M | 66.78% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 513.11M |
| Zura Bio | 508.24M |
| Ocugen | 507.78M |
| Neurogene | 506.13M |
| Sutro Biopharma | 505.73M |
| Cabaletta Bio | 495.69M |
| Shattuck Labs | 493.82M |
| Valneva SE | 482.77M |